Our Services
Medical Information
Helpful Resources
Published on: 9/29/2026
Frontotemporal dementia (FTD) develops when abnormal proteins such as tau, TDP-43, or FUS build up and damage nerve cells in the frontal and temporal lobes, the brain regions that control personality, behavior, judgment, and language. Roughly 10 to 30 percent of cases are inherited through mutations in genes like MAPT, GRN, and C9orf72, so a family history of dementia, ALS, or early behavior changes raises risk, while most other cases occur sporadically with no clear trigger. FTD typically begins between ages 40 and 65, making it a leading cause of dementia in younger adults, and head injury or coexisting motor neuron disease may also play a role. Several risk factors and symptom patterns are easy to confuse with psychiatric illness or Alzheimer's disease, so see below to understand the important distinctions before drawing conclusions.
If you or someone you love is showing personality shifts, loss of empathy, impulsive decisions, or trouble finding words, those signs deserve attention now rather than later, and a free, instant, online symptom check can help you organize what you are noticing, understand possible causes, and see which type of doctor to talk to next.
Last reviewed for medical accuracy: 09/29/2026
Frontotemporal dementia (FTD) is a group of brain disorders that primarily affect the frontal and temporal lobes—areas responsible for behavior, personality, language, and movement. Understanding what causes frontotemporal dementia and who might be at risk can help you recognize early signs, seek appropriate care, and discuss prevention strategies with your healthcare provider.
Frontotemporal dementia differs from other common dementias like Alzheimer’s disease. While Alzheimer’s often begins with memory loss, FTD more typically shows up as changes in behavior, language difficulties, or motor problems. Symptoms can include:
FTD usually strikes people between ages 45 and 65, but it can appear earlier or later. Early detection and accurate diagnosis are key to managing symptoms and planning for the future.
Researchers are still piecing together exactly what causes frontotemporal dementia, but studies point to a combination of genetic, molecular, and environmental factors. Here’s what we know so far:
Genetics play a major role in many cases of FTD.
If you have a relative diagnosed with FTD, genetic counseling can help you understand your personal risk and whether genetic testing makes sense.
Abnormal protein clumps in the brain appear to drive nerve cell damage and death.
These protein changes can start years before symptoms appear. Scientists are working on treatments that target these proteins to slow or stop disease progression.
While genetics and protein biology are the main drivers, research is exploring how lifestyle and environment might influence FTD risk or course.
Knowing who is most likely to develop FTD helps families stay vigilant about early warning signs. Key risk factors include:
While less certain, these may also contribute:
Currently, there’s no guaranteed way to prevent FTD. However, you can take steps to support overall brain health and catch symptoms early.
Keep an eye on changes in behavior, speech, or movement:
If you notice worrisome patterns, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker. This tool can help you decide whether to seek a full medical evaluation.
While these measures can’t guarantee FTD prevention, they support long-term brain resilience:
Always reach out to a healthcare professional if you experience:
Early diagnosis can help you access therapies, plan for the future, and participate in clinical trials. No one should face these changes alone—medical support and community resources are available.
Frontotemporal dementia can feel overwhelming, but knowledge is power. By understanding what causes frontotemporal dementia and recognizing who is at risk, you’re better equipped to notice early signs and take proactive steps. Don’t hesitate to discuss any concerns with your doctor—especially if symptoms are life threatening or seriously interfere with daily activities. And remember, you can start with a free, online symptom check, using the doctor approved Ubie Symptom Checker to guide your next move. Ultimately, partnering with healthcare professionals is the best way to protect your brain health and plan for the future.
(References)
* Palmer HD. The view from 1946: mental disorders of old age, part I. Geriatrics. 2006 Jun;61(6):23-6. PMID: 16768541.
* Sakurai T, Kuranaga M, Takata T, Yamasaki K, Hirai H, Endo H, Yokono K. Association between diastolic blood pressure and lower hemoglobin A1C and frontal brain atrophy in elderly subjects with diabetes mellitus. J Am Geriatr Soc. 2006 Jun;54(6):1005-7. doi: 10.1111/j.1532-5415.2006.00750.x. PMID: 16776802.
* Treusch Y, Jerosch D, Majic T, Heinz A, Gutzmann H, Rapp MA. [How Can we provide better services for demented nursing home residents suffering from apathy?]. Psychiatr Prax. 2010 Mar;37(2):84-8. doi: 10.1055/s-0029-1223472. Epub 2010 Feb 24. PMID: 20183773.
* Frontotemporal dementia. Am Fam Physician. 2010 Dec 1;82(11):1378. PMID: 21121522.
* Gitler AD, Tsuiji H. There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS. Brain Res. 2016 Sep 15;1647:19-29. doi: 10.1016/j.brainres.2016.04.004. Epub 2016 Apr 6. PMID: 27059391; PMCID: PMC5003651.
* Kawada T. Risk Factors of Frontotemporal Dementia with Special Reference to Statistical Validity. Arch Med Res. 2017 Apr;48(3):303. doi: 10.1016/j.arcmed.2017.06.001. PMID: 28923334.
* Chen H, Liu S, Zheng M, Ji L, Wu T, Huang G, Ji Y. Response: Factors Associated with Frontotemporal Dementia in China: A Cross-sectional Study. Arch Med Res. 2017 Apr;48(3):304. doi: 10.1016/j.arcmed.2017.06.002. PMID: 28923335.
* Galimberti D. Genetic risk factors and role of immune dysfunction in FTLD. Nat Rev Neurol. 2019 May;15(5):250-251. doi: 10.1038/s41582-019-0173-5. PMID: 30914791.
* Saracino D, Sellami L, Clot F, Camuzat A, Lamari F, Rucheton B, Benyounes I, Roué-Jagot C, Lagarde J, Sarazin M, Jornea L, Forlani S, LeGuern E, Dubois B, Brice A, Le Ber I. The missense p.Trp7Arg mutation in GRN gene leads to progranulin haploinsufficiency. Neurobiol Aging. 2020 Jan;85:154.e9-154.e11. doi: 10.1016/j.neurobiolaging.2019.06.002. Epub 2019 Jun 10. PMID: 31262553.
* Serpente M, Fenoglio C, Arighi A, Fumagalli GG, Arcaro M, Sorrentino F, Visconte C, Scarpini E, Galimberti D. Analysis of C9orf72 Intermediate Alleles in a Retrospective Cohort of Neurological Patients: Risk Factors for Alzheimer's Disease? J Alzheimers Dis. 2021;81(4):1445-1451. doi: 10.3233/JAD-210249. PMID: 33935096.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.